Loading viewer...
investor_presentation
Format: PDF investor_presentation
Novo Nordisk's nine-month 2016 investor presentation covering highlights, R&D updates, financial performance, and sales updates. Includes forward-looking statements on product development for diabetes and obesity treatments including Victoza and Saxenda.
investor_presentation
13 Pages
Novo Nordisk Full Year 2020 Investor Presentation
investor_presentationinvestor_presentation
130 Pages
Novo Nordisk Full Year 2023 Investor Presentation
investor_presentationinvestor_presentation
163 Pages
investor_presentation
47 Pages
Unknown
Intact Financial Investor Presentation — November 2021
investor_presentationinvestor_presentation
16 Pages
Intact Financial Corporation